His scientific interests lie mostly in Immunology, Virology, T cell, Antigen and Interleukin 21. His Viral replication, Immune system and T-cell receptor study are his primary interests in Immunology. His Virology study incorporates themes from Human leukocyte antigen and Major histocompatibility complex.
His Antigen research incorporates elements of Molecular biology and Viral load. Interleukin 21 is a subfield of Cytotoxic T cell that Rafick Pierre Sekaly studies. He combines subjects such as Cell biology, IL-2 receptor, CCL5 and Antigen-presenting cell with his study of CD8.
Rafick Pierre Sekaly mainly focuses on Immunology, Virology, T cell, Immune system and Cytotoxic T cell. His research in Virology intersects with topics in Interleukin 2 and CTL*. He works mostly in the field of Interleukin 2, limiting it down to concerns involving Interferon gamma and, occasionally, Interleukin.
His T cell study integrates concerns from other disciplines, such as Receptor, Peripheral blood mononuclear cell and Antigen. While the research belongs to areas of Cytotoxic T cell, Rafick Pierre Sekaly spends his time largely on the problem of Cancer research, intersecting his research to questions surrounding Stem cell. His Interleukin 21 study frequently links to other fields, such as IL-2 receptor.
The scientist’s investigation covers issues in Immunology, Virology, Immune system, Cancer research and Inflammation. Rafick Pierre Sekaly combines topics linked to Cytotoxic T cell with his work on Immunology. The study incorporates disciplines such as Proliferative capacity and Antigen in addition to Cytotoxic T cell.
His work on Viremia as part of general Virology research is frequently linked to Nonhuman primate, Cocaine use, Proviral dna and Heroin, bridging the gap between disciplines. His Inflammation study which covers Pathogenesis that intersects with Macrophage and Interferon. His study explores the link between Interleukin 21 and topics such as IL-2 receptor that cross with problems in CD28, Antigen-presenting cell and Natural killer T cell.
His primary areas of investigation include Immunology, Immune system, Immunity, T cell and Virology. Rafick Pierre Sekaly usually deals with Immunology and limits it to topics linked to Lymph and Cellular compartment. His Immune system research is multidisciplinary, relying on both Specific-pathogen-free, Specific Pathogen Free Organism, Blood cell and Laboratory mouse.
He has included themes like Virus latency, Cytotoxic T cell and Cytokine in his T cell study. His Cytokine research includes elements of Interleukin 12, Cell biology, IL-2 receptor and CD8. His Interleukin 21 study is focused on Antigen in general.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Upregulation of PD-1 expression on HIV-specific CD8 + T cells leads to reversible immune dysfunction
Lydie Trautmann;Loury Janbazian;Loury Janbazian;Nicolas Chomont;Elias A. Said.
Nature Medicine (2006)
Skewed maturation of memory HIV-specific CD8 T lymphocytes
P Champagne;G S Ogg;A S King;C Knabenhans.
Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV.
G Pantaleo;J F Demarest;H Soudeyns;C Graziosi.
Normalizing the environment recapitulates adult human immune traits in laboratory mice
Lalit K. Beura;Sara E. Hamilton;Kevin Bi;Jason M. Schenkel.
Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells.
Antoine Alam;Luchino Y. Cohen;Salah Aouad;Rafick-Pierre Sékaly.
Journal of Experimental Medicine (1999)
HIV-1 Viremia Prevents the Establishment of Interleukin 2–producing HIV-specific Memory CD4+ T Cells Endowed with Proliferative Capacity
Souheil Antoine Younes;Bader Yassine-Diab;Alam R. Dumont;Alam R. Dumont;Mohamed Rachid Boulassel.
Journal of Experimental Medicine (2003)
Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals
Cecilia Graziosi;Giuseppe Pantaleo;Kira R. Gantt;Jean-Pierre Fortin.
Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy.
Julian H. Elliott;Fiona Wightman;Ajantha Solomon;Khader Ghneim.
PLOS Pathogens (2014)
Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection.
Marcus Altfeld;Marylyn M. Addo;Eric S. Rosenberg;Frederick M. Hecht.
The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia
Giuseppe Pantaleo;James F. Demarest;Timothy Schacker;Mauro Vaccarezza.
Proceedings of the National Academy of Sciences of the United States of America (1997)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: